8806 Russian patients demonstrate T cell count as better marker of COVID-19 clinical course severity than SARS-CoV-2 viral load

Abstract The article presents a comparative analysis of SARS-CoV-2 viral load (VL), T lymphocyte count and respiratory index PaO2:FiO2 ratio as prospective markers of COVID-19 course severity and prognosis. 8806 patients and asymptomatic carriers were investigated in time interval 15 March–19 Decemb...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Konstantin S. Sharov
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/324300e5e96c4f1a9045585c5bb98726
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:324300e5e96c4f1a9045585c5bb98726
record_format dspace
spelling oai:doaj.org-article:324300e5e96c4f1a9045585c5bb987262021-12-02T14:29:04Z8806 Russian patients demonstrate T cell count as better marker of COVID-19 clinical course severity than SARS-CoV-2 viral load10.1038/s41598-021-88714-62045-2322https://doaj.org/article/324300e5e96c4f1a9045585c5bb987262021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-88714-6https://doaj.org/toc/2045-2322Abstract The article presents a comparative analysis of SARS-CoV-2 viral load (VL), T lymphocyte count and respiratory index PaO2:FiO2 ratio as prospective markers of COVID-19 course severity and prognosis. 8806 patients and asymptomatic carriers were investigated in time interval 15 March–19 December 2020. T cell count demonstrated better applicability as a marker of aggravating COVID-19 clinical course and unfavourable disease prognosis than SARS-CoV-2 VL or PaO2:FiO2 ratio taken alone. Using T cell count in clinical practice may provide an opportunity of early prediction of deteriorating a patient’s state.Konstantin S. SharovNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Konstantin S. Sharov
8806 Russian patients demonstrate T cell count as better marker of COVID-19 clinical course severity than SARS-CoV-2 viral load
description Abstract The article presents a comparative analysis of SARS-CoV-2 viral load (VL), T lymphocyte count and respiratory index PaO2:FiO2 ratio as prospective markers of COVID-19 course severity and prognosis. 8806 patients and asymptomatic carriers were investigated in time interval 15 March–19 December 2020. T cell count demonstrated better applicability as a marker of aggravating COVID-19 clinical course and unfavourable disease prognosis than SARS-CoV-2 VL or PaO2:FiO2 ratio taken alone. Using T cell count in clinical practice may provide an opportunity of early prediction of deteriorating a patient’s state.
format article
author Konstantin S. Sharov
author_facet Konstantin S. Sharov
author_sort Konstantin S. Sharov
title 8806 Russian patients demonstrate T cell count as better marker of COVID-19 clinical course severity than SARS-CoV-2 viral load
title_short 8806 Russian patients demonstrate T cell count as better marker of COVID-19 clinical course severity than SARS-CoV-2 viral load
title_full 8806 Russian patients demonstrate T cell count as better marker of COVID-19 clinical course severity than SARS-CoV-2 viral load
title_fullStr 8806 Russian patients demonstrate T cell count as better marker of COVID-19 clinical course severity than SARS-CoV-2 viral load
title_full_unstemmed 8806 Russian patients demonstrate T cell count as better marker of COVID-19 clinical course severity than SARS-CoV-2 viral load
title_sort 8806 russian patients demonstrate t cell count as better marker of covid-19 clinical course severity than sars-cov-2 viral load
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/324300e5e96c4f1a9045585c5bb98726
work_keys_str_mv AT konstantinssharov 8806russianpatientsdemonstratetcellcountasbettermarkerofcovid19clinicalcourseseveritythansarscov2viralload
_version_ 1718391242581082112